VE20 98% Purity Vesugen KED (Lys-Glu-Asp) CAS 204271-66-9 White Lyophilized Powder Cosmetic & Research Peptide In Stock China Factory
TDS 8 Inquiries
204271-66-9
Pharmaceutical Grade
99.55%
shenzhen
aoxin
20mg*10vials
2026-10-03
GLP-1,Retatrutide,Selank,Tirzepatide
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionResearch & Reference Note
VE20 98% Purity Vesugen KED (Lys-Glu-Asp) CAS 204271-66-9 White Lyophilized Powder Cosmetic & Research Peptide In Stock China Factory is listed on ECHEMI for industrial / laboratory sourcing. This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Authoritative sourcesDisclaimer: This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Reviewed by ECHEMI Scientific Review - Platform editorial review for research chemicals
Certificates-
TDS
Basic Info-
Product Name:
L-Aspartic acid, L-lysyl-L-α-glutamyl-
Other Name:L-Aspartic acid, L-lysyl-L-α-glutamyl-;Visugen
CAS No.:204271-66-9
Molecular Formula:C15H26N4O8
InChIKeys:LLSUNJYOSCOOEB-GUBZILKMSA-N
Molecular Weight:390.39
Categories:
Characteristics-
Density:
1.392±0.06 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted)
Boiling Point:801.365±65.00 °C(Press: 760.00 Torr)(predicted)
PKA:2.797±0.10(predicted)
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
GLP-1,Retatrutide,Selank,Tirzepatide
-
Location:
Room 1402, Unit 1, Building 1, Hongxing Mansion, Shanghang Road Sub-district, Hedong District, Tianjin
-
Payment Terms:
TT against copy of documents
-
Average lead Time:
1
-
Total Annual Revenue:
Less than $1 million
-
Total Employees:
5-10
-
Year of Establishment:
2026
-
-
Inquiry History8 Inquiries
Country Product Purchase Quantity Date Posted
Mexico
Vesugen
1 KG Jan 14, 2026
United States
Vesugen
10 PCS Jun 7, 2026
United States
Vesugen
1 G Mar 26, 2026
United States
vesugen
10 PCS Jun 7, 2026
Australia
Vesugen
10 MG May 28, 2026
Netherlands
Vesugen
1 G Apr 27, 2026
United States
Vesugen
200 MG Apr 9, 2026
United States
vesugen
2 G Mar 10, 2026 Post an enquiry for this product